185 related articles for article (PubMed ID: 8326553)
1. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors.
Eastham JA; Huffman JL
J Urol; 1993 Aug; 150(2 Pt 1):324-5. PubMed ID: 8326553
[TBL] [Abstract][Full Text] [Related]
2. Treatment of urothelial carcinoma of the upper urinary tract following prostatocystectomy with mitomycin C instillation in the ileal loop.
van Helsdingen PJ; Rikken CH
J Urol; 1986 Aug; 136(2):461-3. PubMed ID: 3090277
[TBL] [Abstract][Full Text] [Related]
3. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes.
Audenet F; Traxer O; Bensalah K; Rouprêt M
World J Urol; 2013 Feb; 31(1):45-52. PubMed ID: 23007718
[TBL] [Abstract][Full Text] [Related]
4. Salvage topical therapy for upper tract urothelial carcinoma.
Balasubramanian A; Metcalfe MJ; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
World J Urol; 2018 Dec; 36(12):2027-2034. PubMed ID: 29804202
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy with and without concurrent chemotherapy for locally advanced transitional cell carcinoma of the renal pelvis and ureter.
Czito B; Zietman A; Kaufman D; Skowronski U; Shipley W
J Urol; 2004 Oct; 172(4 Pt 1):1271-5. PubMed ID: 15371822
[TBL] [Abstract][Full Text] [Related]
6. Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
Metcalfe M; Wagenheim G; Xiao L; Papadopoulos J; Navai N; Davis JW; Karam JA; Kamat AM; Wood CG; Dinney CP; Matin SF
J Endourol; 2017 Sep; 31(9):946-953. PubMed ID: 28731777
[TBL] [Abstract][Full Text] [Related]
7. Should patients with primary upper urinary tract cancer receive prophylactic intravesical chemotherapy after nephroureterectomy?
Wu WJ; Ke HL; Yang YH; Li CC; Chou YH; Huang CH
J Urol; 2010 Jan; 183(1):56-61. PubMed ID: 19913833
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Mitomycin Gel (UGN-101) as an Adjuvant Therapy After Complete Endoscopic Management of Upper Tract Urothelial Carcinoma.
Labbate C; Woldu S; Murray K; Rose K; Sexton W; Tachibana I; Kaimakliotis H; Jacob J; Dickstein R; Linehan J; Nieder A; Bjurlin M; Humphreys M; Ghodoussipour S; Quek M; O'Donnell M; Eisner B; Feldman A; Lotan Y; Matin SF
J Urol; 2023 May; 209(5):872-881. PubMed ID: 36657029
[TBL] [Abstract][Full Text] [Related]
9. Endourological management of upper tract urothelial tumors.
Gerber GS; Lyon ES
J Urol; 1993 Jul; 150(1):2-7. PubMed ID: 8510255
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study.
Sakamoto N; Naito S; Kumazawa J; Ariyoshi A; Osada Y; Omoto T; Fujisawa Y; Morita I; Yamashita H;
Int J Urol; 2001 May; 8(5):212-6. PubMed ID: 11328420
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous management of upper-tract transitional cell carcinoma.
Streem SB
Urol Clin North Am; 1995 Feb; 22(1):221-9. PubMed ID: 7855957
[TBL] [Abstract][Full Text] [Related]
12. Antegrade Instillation of UGN-101 (Mitomycin for Pyelocalyceal Solution) for Low-Grade Upper Tract Urothelial Carcinoma: Initial Clinical Experience.
Rosen GH; Nallani A; Muzzey C; Murray KS
J Urol; 2022 Jun; 207(6):1302-1311. PubMed ID: 35130080
[TBL] [Abstract][Full Text] [Related]
13. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
[TBL] [Abstract][Full Text] [Related]
14. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant topical treatment of upper urinary tract urothelial tumours.
O'Donoghue JP; Crew JP
BJU Int; 2004 Sep; 94(4):483-5. PubMed ID: 15329096
[No Abstract] [Full Text] [Related]
16. Minimally invasive approach in the management of upper- urinary-tract tumours.
Adamis S; Varkarakis J
Scand J Urol Nephrol; 2011 Dec; 45(6):381-7. PubMed ID: 22070534
[TBL] [Abstract][Full Text] [Related]
17. Conservative management for transitional cell carcinoma of the upper urinary tract.
Moldwin RM; Orihuela E; Smith AD
Clin Geriatr Med; 1990 Feb; 6(1):163-71. PubMed ID: 2405976
[TBL] [Abstract][Full Text] [Related]
18. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract.
Strong DW; Pearse HD
Cancer; 1976 Nov; 38(5):2173-83. PubMed ID: 991130
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Lymphatic Metastases in Upper Tract Urothelial Carcinoma and Proposed Dissection Templates.
Matin SF; Sfakianos JP; Espiritu PN; Coleman JA; Spiess PE
J Urol; 2015 Dec; 194(6):1567-74. PubMed ID: 26094807
[TBL] [Abstract][Full Text] [Related]
20. Editorial Comment: Adjuvant Single-Dose Upper Urinary Tract Instillation of Mitomycin C After Therapeutic Ureteroscopy for Upper Tract Urothelial Carcinoma: A Single-Centre Prospective Non-Randomized Trial.
de Carvalho JPM
Int Braz J Urol; 2021; 47(1):193-195. PubMed ID: 33047926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
